About ▼ Careers Internship MedBlog Contact us

LOGIN REGISTER

Medindia » News » Drug News » Teva’s Neutropenia Drug Approved by FDA

Teva’s Neutropenia Drug Approved by FDA

by Kathy Jones on Aug 31 2012 7:58 PM

Teva’s Neutropenia Drug Approved by FDA

The US Food and Drug Administration has revealed that it has approved Teva Pharmaceutical Industries’ neutropenia drug that will help increase the production of infection-fighting white blood cell among patients who are undergoing chemotherapy.

With Amgen’s patent for its biologic drug Neupogen expiring next year; the FDA has approved Teva’s tbo-filgrastim, which is similar to Neupogen. However Teva will not be able to market its drug until November 2013 following a settlement of patent litigation with Amgen last year.

Chemotherapy - History, Principles, Aim, Types, Side Effcts, Pros & Cons

Chemotherapy - History, Principles, Aim, Types, Side Effcts, Pros & Cons
'Chemo' means medicine or 'drug', 'therapy' means 'treatment'. Chemotherapy refers to the use of cytotoxic drugs in the treatment of cancer.

Stating that the drug may help patients recover faster from neutropenia, FDA’s Richard Pazdur said, “Supportive care products, such as tbo-filgrastim, reduce or allow for more rapid recovery from side effects of cancer treatments.”

Source-Medindia

About Chemotherapy Drugs

About Chemotherapy Drugs
Chemotherapy drugs perform like ‘magic bullets’ to destroy cancer cells in the body.

Colo-rectal Cancer - Management

Colo-rectal Cancer - Management
Treatment for Colorectal Cancers may involve surgery,chemotherapy, radiation therapy or biological therapy. Some people require a combination of treatments.

Toxoplasmosis - Introduction & Risk factors

Toxoplasmosis - Introduction & Risk factors
Brief overview of a common disease called Toxoplasmosis and its risks in human population

Recommended Readings

Neutropenia

Neutropenia is an abnormal drop in the blood neutrophil count, which may be due to drugs, infections, blood disorders, cancer, or birth defects.

Neutropenic Sepsis

Neutropenic Sepsis

Neutropenic sepsis is a potentially life-threatening condition when a patient with low neutrophil counts develops an infection that spirals out of control if not treated urgently and is usually seen in cancer patients on chemotherapy.

Drug Toxicity

Drug toxicity is an adverse reaction of the body towards a drug that results as a side effect of a drug, reaction to a drug or drug abuse.

Leucopenia / Leukopenia

Leucopenia / Leukopenia

Leucopenia / Leukopenia is a decrease in the number of total white blood cells found in blood. The normal total white cell count is 5000-10000 per cubic millimeter.

Latest Drug News

US FDA Approval of N-803: Ray of Hope For Bladder Cancer Patients

US FDA Approval of N-803: Ray of Hope For Bladder Cancer Patients

The US FDA approves a immunotherapy drug, N-803, for BCG-unresponsive non-muscle invasive bladder cancer, suggested to be used in conjunction with BCG.

Resmetirom For MASH: Approved by US FDA, Increase in Partnerships

Resmetirom For MASH: Approved by US FDA, Increase in Partnerships

The increasing trend in strategic partnerships between innovator companies, and the US FDA approval for Rezdiffra has led to a boost in the development of medications for MASH.

Semaglutide: A Dominant Player for Patients With Heart Failure

Semaglutide: A Dominant Player for Patients With Heart Failure

Data provesSemaglutideefficacy in treatment of Type 2 diabetes, obesity, heart failure, and chronic kidney failure, it emerges as important therapy in metabolic syndrome.

Physician's Lack Agreement – Patients Prefer Branded or Generic Drugs?

Physician's Lack Agreement – Patients Prefer Branded or Generic Drugs?

Generics are not widely used, despite cost advantage, due to a lack of information to patients and reluctance from physicians to prescribe generics - A Need to educate masses

Drug Resistant Melanoma Caused Due to Break in Genes!

Drug Resistant Melanoma Caused Due to Break in Genes!

Studies have led to discovery that drug-resistant melanomas are caused by breaks in the genes, thereby leading to emphasis on alternate targeted therapies to combat cancer.

Advertisement